Apolipoprotein A-IV Cardiac Amyloidosis Diagnosed by Mass Spectrometry–Based Proteomic Analysis
Open Access
- 14 March 2026
- journal article
- case report
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (15) , 107355
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV AmyloidosisCirculation: Cardiovascular Imaging, 2023
- Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosisEuropean Heart Journal, 2023
- Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosisNature Communications, 2022
- Role of mutations and post-translational modifications in systemic AL amyloidosis studied by cryo-EMNature Communications, 2021
- Cardiac Amyloidosis Associated with Apolipoprotein A-IV Deposition Diagnosed by Mass Spectrometry-Based Proteomic AnalysisEuropean Journal of Case Reports in Internal Medicine, 2019
- The pathology and changing epidemiology of dialysis-related cardiac beta-2 microglobulin amyloidosisCardiovascular Pathology, 2019
- Apolipoprotein A-IV–Associated Cardiac AmyloidosisJACC, 2017
- Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosisKidney International, 2016
- Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosisEuropean Heart Journal - Cardiovascular Imaging, 2014